An artificial intelligence system can identify signs of heart disease from routine electrocardiograms (ECGs) in less than two seconds, according to a report published by resultsense.com on September 1, 2026.
The tool analyzes standard ECG data—a common, non-invasive test that records the heart’s electrical activity—to flag potential disease. Resultsense.com describes the detection as near-instantaneous, with the AI completing its assessment in under two seconds. The report does not specify the AI’s accuracy rate, the size of the patient cohort tested, or the clinical setting where the tool was evaluated.
The report follows coverage from other outlets, including The Guardian, which characterized a similar AI tool as “superhuman” for its speed, and distilledpost.com, which also highlighted instantaneous detection. However, the underlying research details—such as the developer of the system, the specific types of heart disease it targets, or any regulatory approvals—were not included in the material available from resultsense.com.
What is notable is the potential for such a tool to fit into existing clinical workflows. ECGs are already performed routinely in hospitals and clinics, so an AI that can interpret them without additional testing could speed up diagnosis. The key limitation is that the report offers no peer-reviewed data or independent validation, meaning the claims rest solely on the publisher’s description.
What to watch next: whether the developers release clinical trial results or seek regulatory clearance, which would determine if this tool moves from research to bedside use.
